From cultivation to distribution, we rely on medicinal cannabis with the highest standards, proven safety and international experience.
Others talk about quality - we deliver it. For us, it's not about hot air, but about the best flowers.




KHIRON patient, male, 56 years old
"My back hurts every day, but I've learned that small steps have a big impact. It's not just about being pain-free, but about quality of life."
KHIRON patient, female, 27 years old
"For years, the pain drained me and dominated my everyday life. Now I can do sport again, enjoy time with friends and finally regain some quality of life."
KHIRON patient, female, 39 years old
"Long nights without sleep left me exhausted. Now I know ways to relax my body and finally recharge my batteries for the day."
You ask,
we answer.
Seit April 2024 erlaubt die Teillegalisierung „CanG“ den Besitz bestimmter Mengen Cannabis für den Eigenbedarf und erleichtert den Zugang zu medizinischen Therapien. Cannabis gilt nicht mehr als Betäubungsmittel nach dem BtMG, sondern unterliegt dem Cannabisgesetz (KCanG) und – im medizinischen Bereich – dem Medizinal-Cannabisgesetz (MedCanG). Medizinisches Cannabis wird nun mit einem normalen E-Rezept verordnet.
Seit Oktober 2024 entfällt die Genehmigungspflicht der Krankenkasse für die Erstverordnung von medizinischem Cannabis für die meisten Facharztgruppen. Dadurch wurde das Verfahren rechtlich vereinfacht und bürokratischer Aufwand in der Theorie reduziert.
In der Praxis verordnen viele Ärztinnen und Ärzte jedoch weiterhin zurückhaltend, da sie Wirtschaftlichkeitsprüfungen und mögliche Regressforderungen befürchten. Deshalb bleiben Privatrezepte häufig der schnellere und oft auch realistischere Weg zu einer Cannabistherapie.
Die Bundesregierung hat am 10. Juli 2026 das neue GKV-Beitragssatzstabilisierungsgesetz (BStabG) beschlossen, um die Ausgaben der gesetzlichen Krankenversicherung (GKV) zu begrenzen. Die für die Versorgung mit Medizinalcannabis maßgeblichen Änderungen des § 31 Abs. 6 SGB V sind am 30. Juli 2026 in Kraft getreten.
Mit Inkrafttreten des Gesetzes übernimmt die gesetzliche Krankenversicherung keine Kosten für Cannabisblüten mehr. Der Leistungsanspruch gilt nur noch für standardisierte Cannabisextrakte sowie Arzneimittel mit Dronabinol oder Nabilon.
Außerdem darf Medizinisches Cannabis grundsätzlich erst zulasten der GKV verordnet werden, wenn zuvor ein sechsmonatiger Therapieversuch mit einem zugelassenen cannabishaltigen Fertigarzneimittel erfolgt ist. Ärztinnen und Ärzte können medizinisches Cannabis jedoch weiterhin verordnen. Übernimmt die GKV die Kosten nicht, kann die Behandlung auf Privatrezept erfolgen.
In Germany, all doctors registered with the national health insurance system are generally permitted to prescribe medical cannabis; dentists are excluded from this. There is no requirement for a specialist referral.
In practice, however, not all practices have experience with cannabinoid therapies. Specialist doctors - for example from the fields of pain therapy, neurology or oncology - often take over the treatment in order to provide optimal support for the therapy.
Medicinal cannabis preparations can be used in various areas under medical supervision. The most common applications include
Chronic pain, especially neuropathic pain
Spasticity, for example in multiple sclerosis
Nausea and vomiting as a result of chemotherapy
Epilepsy, especially rare, therapy-resistant forms
Sleep disorders
Anxiety disorders
Which therapy is appropriate in each individual case depends on the diagnosis, the course of treatment to date and the doctor's assessment.
The form of administration depends on the prescribed dosage form and the therapeutic objective:
Inhalation of flowers via a medical vaporizer (vaporizer)
Oral administration as standardized drops, capsules or solutions
Ready-to-use medicines such as sprays or tablets, depending on the doctor's prescription
The appropriate form is selected on an individual basis according to medical assessment and therapy requirements.
Medicinal cannabis is grown under controlled conditions, is microbiologically tested and standardized for its THC and CBD content. It meets strict quality standards in accordance with the German Pharmacopoeia.
Recreational cannabis is not subject to these standards. Composition, active ingredient content and purity can therefore vary greatly.
Yes, the consumption of medicinal cannabis is generally permitted in public with a valid doctor's prescription. To avoid misunderstandings during police checks, it is advisable to carry a copy of the prescription or a current doctor's letter with you.
Local regulations such as smoking bans in non-smoking areas, public buildings, train stations or means of transportation continue to apply.
Yes, driving is generally permitted as long as your ability to drive is not impaired. Please note:
Dosing phase: You should not drive a vehicle during the adjustment phase.
After taking preparations containing THC: Wait at least 4-6 hours, as the ability to react may be limited during this time.
Proof at check-ups: Carry a copy of the prescription or a doctor's letter with you to prove the medical prescription.
Your own assessment: Only ride if you feel safe and fit to ride.
Hier mehr lesen: Regeln, Konsequenzen und worauf Patienten bei Cannabis am Steuer achten sollten
Yes, travel is possible, but certain rules apply:
Within the Schengen area: With a special certificate in accordance with the Schengen Agreement, you may carry your prescribed quantities with you. This certificate is issued by your treating doctor and must be certified by the competent authority before you travel.
Outside the Schengen area: The regulations vary from country to country. Check with the BfArM or the Federal Foreign Office in good time to find out whether and under what conditions import is permitted.
Hier mehr lesen: Reisen mit Cannabis? „How to“ und Checkliste für Patienten
KHIRON stands for an open, modern approach to cannabis. For all those who have questions.
Contact us now and find out more.